Biotechnology
31 results total, viewing 21 - 30
Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien PLC for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages. more
Nabsys Inc. has begun a search for CEO candidates with experience in life sciences commercialization, as the company moves closer to bringing its high-speed DNA sequencing technology to market, current CEO Dr. Barrett Bready told Providence Business News. more
Steve Lombardi has been named CEO and president of Nabsys Inc., a life sciences company pioneering semiconductor-based tools for genomic analysis. more
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the four winners of its second annual Rhode Island Bioscience Awards. more
Tech Collective, an industry association for information technology and bioscience, has announced a call for applicants for its 2014 Rhode Island Bioscience Awards, the program’s second year following its launch in 2013. more
Amgen Inc., the world’s biggest biotechnology company by sales, reported second-quarter earnings that beat analysts’ estimates and raised its profit estimate for the year. more
U.S. stocks fell a second day from record levels, with the Nasdaq Composite Index tumbling the most since April, as investors sold Internet and biotechnology shares before the start of earnings season. more
U.S. stocks fluctuated as investors weighed better-than-estimated bank earnings against Federal Reserve concerns about valuations for some social-media and biotech companies. more
Amgen Inc., the world’s largest biotechnology company by revenue, disappointed analysts with lower-than-expected sales of its top drug as executives assured investors the drop was seasonal and they were on target to meet their 2014 projections. more
The biosciences comprise a burgeoning industry and important opportunity for Rhode Island. The state’s bioscience industry employs 4,602 bioscience professionals and has a total employment impact of an additional 11,847 workers. On a national and global scale, Rhode Island bioscience companies and professionals participate in the industry’s five primary sectors: drugs and pharmaceuticals; medical devices and equipment; research, testing, and medical laboratories; agricultural feedstock and chemicals; and bioscience-related distribution. more
« Prev | 1 | 2 | 3 | 4 Next »
Calendar
PBN Hosted
Events

Applications are now being accepted for the 14th Annual Business Excellence Awards Program. Deadline to apply is October 1st. And save the date for the Awards Dinner - November 12th at the Providence Marriott.
Advertisement
Purchase Data
Book of Lists
Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  •  
  • Purchase an e-File of the entire Book of Lists database
  •  
  • Purchase a printed copy of the Book of Lists
  •  
    National
    Local
    Latest News
    Advertisement